ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
First Trust Cloud Computing Ucits Etf

First Trust Cloud Computing Ucits Etf (SKYE)

51,53
-1,20
( -2,28% )
Mis à jour : 09:44:56

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
51,53
Prix Achat
51,50
Prix Vente
51,61
Volume échangé
650
51,51 Fourchette du Jour 51,67
0,00 Plage de 52 semaines 0,00
Clôture Veille
52,73
Ouverture
51,61
Dernière Transaction
17
@
51.53
Dernière heure de transaction
09:13:17
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

SKYE Dernières nouvelles

Newbridge Announces Nanotechnology Index (NYSEArca: NNIX) Quarterly Rebalance and Inside Nanotechnology 2Q07 Research Report Rel

FORT LAUDERDALE, Fla., May 21 /PRNewswire/ -- Newbridge Securities Corporation today announced the quarterly rebalancing and reconstitution of its Newbridge Nanotechnology Index (NYSEArca:...

SkyePharma Reports Positive Phase III and EU Filing for Lodotra(TM)

LONDON, Oct. 4 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) today announces positive results of a Phase III clinical trial for Lodotra(TM), a new, modified-release tablet...

SkyePharma to Reorganise Certain Management Functions

LONDON, Sept. 22 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces today that as part of the Company's ongoing initiatives to increase operational efficiency the...

SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe

Euro 15 million upfront and Euro 70 million in milestones Double Digit Royalties LONDON, Sept. 6 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP) ( NASDAQ: SKYE) announces today that it has...

SkyePharma to Announce 2006 Interim Results on 28 September

LONDON, Sept. 5 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE:Nasdaq:LSE:SKYE) announces today that the Company will issue its interim results for the six months ended 30 June 2006 to the...

SkyePharma PLC - Annual General Meeting Statement

LONDON, June 28 /PRNewswire-FirstCall/ -- The Annual General Meeting of SkyePharma plc (LSE:SKPLSE:Nasdaq:LSE:SKYE) was held in London today. All resolutions were passed, with the minimum...

SkyePharma's Chief Operating Officer Appointed to Board

LONDON, May 17 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP)(NASDAQ: SKYE) announces the appointment of Dr Ken Cunningham, Chief Operating Officer, as a Director of the Company. It was...

SkyePharma and Kos to Host Teleconference Today on US Marketing and Distribution Agreement for Flutiform(TM)

LONDON, May 8 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP)(NASDAQ: SKYE) and Kos Pharmaceuticals, Inc. (Nasdaq: KOSP, "Kos") will host a joint teleconference later today to discuss the US...

SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States

LONDON, May 8 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKP)(NASDAQ: SKYE) announces today that it has entered into an agreement with Kos Pharmaceuticals, Inc. (NASDAQ:KOSP) ("Kos") to...

SkyePharma Announces First European Approval of DepoDur(TM)

Innovative Single Epidural Injection 48 Hours of Post-Surgical Pain Relief LONDON, April 28 /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE:Nasdaq:LSE:SKYE)) announces today that the UK...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock